Quotient is the leading digital media and promotions technology company that creates cohesive omnichannel brand-building and sales-driving opportunities to deliver valuable outcomes for advertisers, retailers, and consumers. Their platform utilizes consumer spending data, location intelligence, and purchase intent data to reach millions of shoppers daily and drive measurable, incremental sales.

Our Somatic Genomics platform unveils a new universe of genetic variation to create transformational medicines. Learn more at Quotient-Tx.com

Quotient Therapeutics

Our platform reveals new approaches to treat disease based on the vast genetic variation present in the body’s trillions of cells. Check out what Professor Sir Mike Stratton, Academic Co-Founder and Senior Group Leader at the Wellcome Sanger Institute shared about our technology and its potential: https://lnkd.in/eiG938bH

We are Quotient Therapeutics, pioneering #SomaticGenomics to make transformative medicines. Our proprietary technology reveals naturally selected genes that can be targeted to treat a multitude of different diseases through a wide variety of therapeutic modalities, enabling near limitless possibilities. 

Explore the next frontier in genetics here: https://lnkd.in/eurVuxyX #FlagshipFounded

COM:QUOTIENT-TX

Quotient Technology Inc.

Analysis Not Available